Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: The Bern–Rotterdam diabetes cohort study-Reference-Cited by-同舟云学术

Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: The Bern–Rotterdam diabetes cohort study

Published:2013-12 Issue:1 Volume:170 Page:36-42
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Simsek C.,Räber L.,Magro M.,Boersma E.,Onuma Y.,Stefanini G.G.,Zanchin T.,Kalesan B.,Wenaweser P.,Jüni P.,van Geuns R.J.,van Domburg R.T.,Windecker S.,Serruys P.W.J.C.

Funder

Nederlandse Hartstichting

Swiss National Science Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Prevalence of obesity, and obesity-related health risk factors, 2001;Mokdad;JAMA,2003

2. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials;Cutlip;Circulation,2004

3. Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials);Lee;Am J Cardiol,2006

4. Coronary heart disease in patients with diabetes II: recent advances in coronary revascularization;Berry;J Am Coll Cardiol,2007

5. Potential mechanisms promoting restenosis in diabetic patients;Aronson;J Am Coll Cardiol,1996

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the progress and potential of drug-eluting stents and drug-coated balloons in cardiological insurgencies;Life Sciences;2024-09

2. Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock;PLOS ONE;2019-04-03

3. Cardiac Versus Non-Cardiac Related Mortality Following Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis;Diabetes Therapy;2018-05-19

4. Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis;Diabetes Therapy;2018-04-11

5. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Progress in Cardiovascular Diseases;2018-01